Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vanqua Bio logo — Vanquishing Neurodegeneration.

Vanqua Bio

Vanquishing Neurodegeneration.

Founded 2019 United States Chicago, United States 32 employees Series Unknown Biotechnology, Health Care

General Information

Company Name Vanqua Bio
Founded Year 2019
Location United States Chicago, United States +1
Employees 32
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Vanqua Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vanqua Bio

Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).

No funding data available for Vanqua Bio yet.

Get notified when Vanqua Bio raises funding

Vanqua Bio Alternatives & Competitors

Vanqua Bio vs
Enterin Inc.
Enterin Inc. United States

Improving the quality of life of patients with neurodegenerative conditions by repairing the gut-bra...

Series Unknown
18 employees
Biopharma, Biotechnology
Compare Vanqua Bio vs Enterin Inc.
Vanqua Bio vs
Anacalypsis Therapeutics
Anacalypsis Therapeutics Greece

An early stage biotech company making life-changing discoveries for patients with neurodegenerative...

2 employees
Biotechnology
Vanqua Bio vs
Satori Pharmaceuticals
Satori Pharmaceuticals

Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases.

Series Unknown
Health Care, Pharmaceutical
Compare Vanqua Bio vs Satori Pharmaceuticals
Also compare with: Vanqua Bio vs Circumvent Circumvent

FAQ About Vanqua Bio

Vanquishing Neurodegeneration.
Vanqua Bio was founded in 2019.
Vanqua Bio is headquartered in Chicago, United States.
Vanqua Bio operates in the following industries: Biotechnology, Health Care.
Vanqua Bio has approximately 32 employees.
Top alternatives and competitors to Vanqua Bio include Enterin Inc., Anacalypsis Therapeutics, Satori Pharmaceuticals, Circumvent, Kineta (Reverse Merger With Yumanity Therapeutics). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vanqua Bio and Enterin Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vanqua Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy